Background: Parkinson’s disease is a progressive neurodegenerative disease marked by extrapyramidal symptoms that promote unproductiveness and dependence. Objectives: The study aimed to assess the variation in the mortality rate from Parkinson’s Disease in Brazil between the years 2009 and 2019. Design and setting: Descriptive and retrospective study in Brazil. Methods: Data were collected through the SIM in DATASUS database. The population consisted of all patients who died from Parkinson’s Disease in the proposed period, selected according to the CID G20. The data were stratified by incidence of deaths per 100.000 inhabitants, gender and age group. For statistical analysis, SPP software version 21.0 was used. Results: Between 2009 and 2019, there were 36.621 deaths due to Parkinson’s Disease. The incidence of death per 100,000 inhabitants was 1.26 in 2009; 1.36 in 2010; 1.44 in 2011; 1.53 in 2012; 1.51 in 2013; 1.65 in 2014; 1.64 in 2015; 1.75 in 2016; 1.81 in 2017; 2.01 in 2019; and 2.18 in 2019. Considering all deaths, there is a predominance of males (54.7%) over females (45.3%). Besides, in relation to the age group, the groups with the highest number of deaths were those between 70 and 79 years old (30.9%) and with more than 80 (57.7%). Conclusions: There is an increase in the Parkinson’s mortality rate between 2009 to 2019. Furthermore, the data are in agreement with the existing epidemiological literature, given the fact that the highest prevalence of deaths from Parkinson’s occurs in men over 70 years. MeSH terms: Parkinson Disease, Epidemiology, Mortality.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.